[1]许慧阳, 侯为顺, 蒯荟芬.血钠水平在肝硬化中的临床意义[J].实用全科医学, 2006, 4 (3) :278-279.
|
[2]中华医学会.病毒性肝炎防治方案[J].中华肝脏杂志, 2000, 8 (6) :324-329.
|
[3] 陈灏珠.实用内科学[M].第10版.北京:人民卫生出版社, 1997:1673.
|
[4]Gines P, Jimnez W.Aquaretic agent s:a new potential treatment of dilutional hyponat remia in cirrhosis[J].J Hepatol, 1999, 24 (4) :506-512.
|
[5]李卫东, 宫彦英, 曲韬.肝硬化腹水低钠血症52例转归分析[J].现代医学, 2004, 32 (2) :95-96.
|
[6]Bradley EA, Reidy JF, Forman RG, et al.Transcatheter uterine ar-tery embolisation to treat large uterine fibroids[J].Br J Obstet Gyne-col, 1998, 105 (2) :235.
|
[7]李井华, 罗忠金.肝硬化失代偿期并发低钠血症的原因及治疗现状[J].实用临床医学, 2008, 9 (9) :136-137.
|
[8]曾欣, 林勇, 谢渭芬.关于肝硬化腹水治疗中“限钠”之我见[J].中华消化杂, 2007, 27 (5) :331-333.
|
[9]Forman LM, Lucey MR.Predicting the prognosis of chronic liver dis-ease:an evolution fromChild to MELD.Mayo End-stage Liver Dis-ease[J].Hepatology, 2001, 33 (2) :473-475.
|
[10]方国平, 张锁才, 孔启源, 等.60例肝炎后肝硬化腹水的低钠血症治疗及转归分析[J].肝脏, 2002, 7 (1) :32-33.
|
[1] | Ding Tao, Wei Jian, He XuDong. Lamivudine antiviral treatment after radical surgery prolongs disease-free survival of patients with hepatitis B virus-related liver cancer[J]. Journal of Clinical Hepatology, 2017, 33(8): 1497-1501. doi: 10.3969/j.issn.1001-5256.2017.08.017 |
[2] | Yang DongQiang, Chen Fang, Kang Yi, Ding GangQiang, Xiao ErHui, Peng Zhen, Shang Jia. Genotypes and resistance loci in patients with chronic hepatitis B achieving virologic breakthrough in treatment with lamivudine combined with adefovir after developing drug resistance in treatment with lamivudine alone[J]. Journal of Clinical Hepatology, 2016, 32(3): 480-483. doi: 10.3969/j.issn.1001-5256.2016.03.016 |
[3] | Song MinNing, Huang WenQi, Min Feng, Hong MeiZhu, Fan RongHua, Wu WeiBing, Zhang Li. The efficacy of 3 years adefovir monotherapy in chronic hepatitis B patients with lamivudine resistance[J]. Journal of Clinical Hepatology, 2012, 28(1): 29-32. |
[4] | Yang YanLin, Xiao Ping, Gao Peng, Wang LiMing, Wei XiSheng, He Qiang, Zhou Ping. Distribution of HBV genotypes and YMDD mutations in E antigen-positive patients[J]. Journal of Clinical Hepatology, 2012, 28(6): 428-430. |
[6] | Su MingHua, Jiang JianNing, Zhou YuanPing, Chen MaoWei, Liu ZhiHong. Study of the relationship between BCP mutation in the hepatitis B virus gene and HBVDNA rebound after lamivudine therapy[J]. Journal of Clinical Hepatology, 2008, 24(3): 172-174. |
[8] | Li Jun, Chen XinYue, Zhao Hong, Yu YanYan, Si ChongWen, Han ZhongHou, Zhang WenJin, Chen YuPing, Chen Yong, Wang GuiQiang, Yu Min, Gong WeiBo, Xu JingHang, Wang Jun, Lin XiaoHong, Li XueYing. The relationship of hepatitis B virus genotypes and efficacy of lamivudine and interferon alpha 2b in the treatment of HBeAg-positive chronic hepatitis B[J]. Journal of Clinical Hepatology, 2008, 24(3): 169-171. |
[10] | Wang YuMin, Tao ZhiHua, Zhu YanYing, Lin XiaoMei. Detecting of the hepatic fibrotic indexes and serous markers from patients with chronic hepatitis B (CHB) and variation of HBV DNA YMDD[J]. Journal of Clinical Hepatology, 2007, 23(3): 174-176. |
[11] | Qiu YuanWang, Chen ShiBin, Yang Qian, Yi DongYing. A study on the disease progression of chronic Hepatitis B with YMDD variation and its clinical management[J]. Journal of Clinical Hepatology, 2007, 23(6): 421-423. |
[14] | Gu QiangYe, Chen HeMin. Therapeutic efficacy of combined application of Lamivudine and Ganluoxinpills in treating chronic hepatitis B and its in fluence on YMDD motif[J]. Journal of Clinical Hepatology, 2005, 21(2): 79-80. |
[15] | Tian DeYing, Xu Dong, Xing MingYou, Guo Wei, Song PeiHui. Research on relationship of HBV YMDD mutation and lamivudine resistance.[J]. Journal of Clinical Hepatology, 2004, 20(3): 161-162. |
[16] | Jiang WeiPing, Lai LiYing, Li XinHua, Chen DongPing. Study on the linkage between variation of YMDD in hepatitis B virus and hepatic fibrosis serum markers[J]. Journal of Clinical Hepatology, 2004, 20(6): 345-346. |
[17] | Ding QiaoYun, Zhang HanRong. Lamivudine therapy in chronic hepatitis B causing severe hepatitis.[J]. Journal of Clinical Hepatology, 2003, 19(6): 351-352. |
[18] | Zhao Wei, Wan JianMin, Liu Wei, Liu QuanJun, Zhang Lin, Zhang HanRong, Liu XinYu, Zhou ZhenXian. Detection and identification of emergence of HBV YMDD motif mutation during lamivudine treatment by hybridization to an oligonucleotide array[J]. Journal of Clinical Hepatology, 2003, 19(3): 178-180. |